<DOC>
	<DOC>NCT00210067</DOC>
	<brief_summary>The purpose of this trial is to access the tolerability of INS37217 Intravitreal Injection when administered intravitreally in subjects with macula-on or macula-off rhegmatogenous retinal detachment (RRD).</brief_summary>
	<brief_title>A Study in Subjects With Retinal Detachment</brief_title>
	<detailed_description />
	<mesh_term>Retinal Detachment</mesh_term>
	<mesh_term>Dissociative Disorders</mesh_term>
	<criteria>have maculaon or maculaoff rhegmatogenous retinal detachment are eligible for pneumatic retinopexy, with identifiable retinal breaks are phakic or pseudophakic have detachments not of a rhegmatogenous nature currently have blood in the vitreous, corneal opacity, or other conditions which limit the view of peripheral retina have evidence of intraocular inflammation (uveitis) have a history of current condition of uncontrollable, elevated IOP or openangle glaucoma have breaks not conducive to a single procedure of pneumatic retinopexy treatment have proliferative vitreoretinopathy of type C or D have previously had a vitrectomy or require one have previously had a scleral buckle procedure</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>